[ad_1]
Howdy,
Welcome to Insider Healthcare. I am healthcare editor Leah Rosenbaum, and this week in healthcare information:Should you’re new to this text, join right here. Feedback, ideas? E mail me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let’s get to it…
FatCamera/Getty Photos
Leaders share what’s in retailer for the industryThough the 2021 HLTH convention ended final week, our reporters are nonetheless bringing you information and interviews from these days in Boston.
This week, reporters Mohana Ravindranath and Shelby Livingston wrote a couple of new partnership between Highmark Well being, an $18 billion healthcare system, and Verily. The 2 big firms are partnering in an effort to extend value-based care. In the meantime reporter Andrew Dunn wrote about his interviews with biotech entrepreneur Alexis Borisy, and why EQRx is Borisy’s largest enterprise but.Andrew additionally spoke to chief Regeneron scientist George Yancopoulos, who had some recommendation for all of the CRISPR-based gene modifying firms on the market. See all of the protection>> The CEO of an $18 billion well being system shared the way it’s partnering with Verily to remodel the best way docs present care
Getty Photos/MirageC
What healthcare buyers fear about Additionally at HLTH, reporter Megan Hernbroth spoke to institutional healthcare buyers who mentioned they had been fearful concerning the sudden improve of money within the house from tech buyers like Tiger International Administration.
They are saying that these large influxes of money are partially answerable for pushing firm valuations to astronomically excessive ranges. Our reporters famous different new funding information this week. Mohana wrote about why buyers appear to be thinking about Cityblock, regardless that it is a startup within the historically underfunded Medicaid sector. And Lydia Ramsey Pflanzer and Blake Dodge reported on a startup geared in the direction of enhancing healthcare for older adults.Test it out now>>This is why longtime healthcare buyers urge warning towards the inflow of funding from tech corporations like Tiger International Administration
On this Tuesday, Aug. 10, 2021 file photograph, College students, some carrying protecting masks, arrive for the primary day of college at Sessums Elementary Faculty in Riverview, Fla.
AP Photograph/Chris O’Meara, File
A COVID-19 vaccine for youths could possibly be licensed any day nowThis week, Andrew reported that an FDA advisory panel voted to suggest that the company authorize a lower-dose model of the Pfizer COVID-19 vaccine for youths aged 5 to 11 years previous. Whereas the FDA does not must agree with its professional panel, the company normally does.
Which means vaccines for younger youngsters could possibly be coming any day, accompanied by a extra kid-friendly needle, based on science editor Erin Schumaker. In additional encouraging COVID-19 information, a big examine simply discovered that an affordable and customary antidepressant known as fluvoxamine lowers the chance of hospitalization from COVID-19 in high-risk sufferers, Erin Snodgrass wrote. Learn extra>>The FDA’s professional panel simply gave a thumbs-up for Pfizer’s COVID-19 vaccine in youthful youngsters, clearing the trail for authorization in a matter of daysMore tales that stored us busy this week: -Leah
Loading
One thing is loading.
[ad_2]